Showing results (1021-1030 of 4,634) with videos related to

Sort By:
Pageof 464
Anti-Cancer Drugs|April 16, 2019
Propranolol suppresses infantile hemangioma cell proliferation and promotes apoptosis by upregulating miR-125b expressionJiajia Huang, Dongdong Jiang, Shasha Zhao, et al.
Anti-Cancer Drugs|August 23, 2018
Efficacy and safety of raltitrexed-based transarterial chemoembolization for colorectal cancer liver metastasesGuoliang Shao, Ruibao Liu, Wenbin Ding, et al.
Anti-Cancer Drugs|August 23, 2018
Cetirizine and thalidomide synergistically inhibit mammary tumorigenesis and angiogenesis in 7,12-dimethylbenz(a)anthracene-treated ratsIlya D Ionov, Nicholas P Gorev, Larissa A Roslavtseva, et al.
Anti-Cancer Drugs|October 19, 2012
Hypertension as a biomarker in patients with recurrent glioblastoma treated with antiangiogenic drugs: a single-center experience and a critical review of the literatureGiuseppe Lombardi, Fable Zustovich, Patrizia Farina, et al.
Anti-Cancer Drugs|March 26, 2010
Induction of apoptosis and inhibition of prostate and breast cancer growth by BGP-15, a new calcipotriene-derived vitamin D3 analogLiron Berkovich, Shimon Ben-Shabat, Amnon C Sintov
Anti-Cancer Drugs|March 27, 2015
ERK-dependent phosphorylation of HSF1 mediates chemotherapeutic resistance to benzimidazole carbamates in colorectal cancer cellsChristina T K Wales, Frederick R Taylor, Allan T Higa, et al.
Anti-Cancer Drugs|November 15, 2022
Potential mechanism of pyrotinib-induced diarrhea was explored by gut microbiome and ileum metabolomicsJingjiang Lai, Xiaoli Zhuo, Ke Yin, et al.
Anti-Cancer Drugs|August 10, 2022
Ado-trastuzumab emtansine in the treatment of lung adenocarcinoma with ERBB2 mutation: a case report and literature reviewHao Wang, Yang He, Weipeng Zhao, et al.
Anti-Cancer Drugs|August 10, 2022
Response to trametinib in a nonsmall cell lung cancer patient with osimertinib resistance harboring GNAS R201C and R201H mutations: a case reportYou Lv, Chao Zhou, Zhonghai Chen, et al.
Anti-Cancer Drugs|August 10, 2022
The effect of angiotensin receptor blockers and angiotensin-converting enzyme inhibitors on progression of gastric cancer: systematic review and meta-analysisSeyed Ali Mehrdad, Farshad Mirzavi, Seyed Mohammad Reza Seyedi, et al.
Pageof 464